|
|
ix | |
Preface |
|
xv | |
|
1 Role of TRAIL-mediated signaling as Jekyll and Hyde in metastasis: changing places, changing faces |
|
|
|
|
|
|
|
|
1 | (2) |
|
Darker side of caspase-8: nonapoptotic caspase-8---mediated functionalities |
|
|
3 | (1) |
|
TRAIL-mediated NF-kB activation: friend or foe |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
5 | (2) |
|
2 Multiple roles of circulating tumor cells and exosomes in cancer metastasis: implications for therapeutic intervention |
|
|
|
|
|
7 | (1) |
|
|
8 | (1) |
|
CTCs involvement in metastatic progression |
|
|
9 | (3) |
|
Exosomes involvement in metastatic progression |
|
|
12 | (3) |
|
Clinical impact of CTCs and exosomes |
|
|
15 | (1) |
|
Conclusions and future perspectives |
|
|
16 | (1) |
|
|
17 | (7) |
|
3 Diagnosis and treatment of metastatic prostate cancer: the role of imaging, liquid biopsies, and biomarkers for deciphering tumor heterogeneity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 | (1) |
|
Overview of prostate cancer disease states and treatment options |
|
|
25 | (5) |
|
Improved imaging and image-guided biopsy for prostate cancer |
|
|
30 | (3) |
|
Gene signature panels for prostate cancer risk stratification |
|
|
33 | (2) |
|
Next-generation sequencing and prostate cancer: cell-free nucleic acids and circulating tumor cells |
|
|
35 | (2) |
|
|
37 | (1) |
|
|
37 | (1) |
|
|
37 | (12) |
|
4 Prognostic and predictive role of bone metastasis in NSCLC: risk factors and clinical implications |
|
|
|
|
|
|
49 | (2) |
|
Incidence of BMs in NSCLC patients |
|
|
51 | (1) |
|
|
51 | (4) |
|
|
55 | (1) |
|
Risk factors for bone metastasis |
|
|
56 | (2) |
|
Clinical implication and treatment |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (4) |
|
5 Brain metastases in breast cancer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64 | (1) |
|
The basis of breast cancer brain metastasis |
|
|
65 | (5) |
|
Risk factors for brain metastasis in breast cancer |
|
|
70 | (1) |
|
|
70 | (1) |
|
|
71 | (2) |
|
|
73 | (1) |
|
|
73 | (3) |
|
|
76 | (11) |
|
6 Noncoding way of the metastasis |
|
|
|
|
|
|
|
|
87 | (1) |
|
Dual role of small noncoding RNAs in metastasis |
|
|
88 | (1) |
|
Long noncoding RNAs and metastasis |
|
|
89 | (8) |
|
|
97 | (1) |
|
|
97 | (9) |
|
7 Nanotechnology based docetaxel: upcoming avenue for breast cancer management |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106 | (1) |
|
Classification of breast cancer |
|
|
107 | (2) |
|
Pathogenesis of breast cancer |
|
|
109 | (2) |
|
Causative factors and associated risks of breast carcinoma |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
Treatment strategies for breast cancer |
|
|
112 | (6) |
|
Nanoparticle platforms currently employed or explored clinically in MBC |
|
|
118 | (2) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
120 | (5) |
|
8 Metastasis in gynecological cancers |
|
|
|
|
|
|
|
|
Pierluigi Benedetti Panici |
|
|
|
125 | (1) |
|
Key steps and patterns of metastasis among gynecological cancers |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (1) |
|
Future directions: targeted therapy |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
132 | (6) |
|
9 Regulation of HSP90 by noncoding RNAs in carcinogenesis and metastasis: harbingers of good or evil |
|
|
|
|
|
|
Ishmuratova Margarita Yulaevna |
|
|
|
|
138 | (1) |
|
Oncogenic role of HSP90 and miRNAs |
|
|
138 | (1) |
|
Tumor suppressive role of HSP90 and miRNAs |
|
|
138 | (1) |
|
Targeting of HSP90 by tumor suppressor miRNAs |
|
|
139 | (1) |
|
Regulation of HSP90 by IncRNAs |
|
|
139 | (1) |
|
|
139 | (1) |
|
Partnership of IncRNAs with HSP90 to promote stability of oncogenic proteins: oncogenic role of IncRNAs |
|
|
140 | (1) |
|
Partnership of IncRNAs with HSP90 to promote stability of tumor suppressor proteins: tumor suppressor role of IncRNAs |
|
|
141 | (1) |
|
LncRNAs protect HSP90 from targeting by miRNAs |
|
|
141 | (1) |
|
Regulation of HSP90 by circular RNAs |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
142 | (3) |
|
10 Role of circular RNAs in carcinogenesis and metastasis: closer analysis of unresolved mysteries |
|
|
|
|
|
|
|
|
|
145 | (1) |
|
Tumor suppressor circular RNAs |
|
|
146 | (3) |
|
Oncogenic role of circular RNAs |
|
|
149 | (2) |
|
|
151 | (1) |
|
|
151 | (2) |
|
11 Metastatic potential: focus on lipid transport with emphasis on CD36 |
|
|
|
|
|
|
|
|
|
153 | (1) |
|
Cellular lipids for metastasis---where do they come from? |
|
|
154 | (1) |
|
Families of lipid transporters---positioning in classifications |
|
|
154 | (4) |
|
Dietary lipids can drive metastasis |
|
|
158 | (2) |
|
Supporting cancer cell colonization---pro-survival signalling |
|
|
160 | (3) |
|
|
163 | (1) |
|
Low metastatic potential versus high metastatic potential |
|
|
164 | (3) |
|
|
167 | (1) |
|
|
168 | (1) |
|
|
168 | (1) |
|
|
169 | (6) |
|
12 Developmental genes: the bridge between development and cancer metastasis |
|
|
|
Tania Cristina Leite de Sampaio e Spohr |
|
|
|
175 | (1) |
|
Transforming growth factor beta |
|
|
176 | (2) |
|
|
178 | (1) |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
183 | (4) |
|
13 Heat shock proteins in tumor progression and metastasis |
|
|
|
|
|
|
|
187 | (1) |
|
Structure---function relationship of HSPs |
|
|
188 | (1) |
|
Role of distinct HSPs in oncogenic progression and in metastasis |
|
|
189 | (4) |
|
Epigenetic alterations of HSPs in cancer |
|
|
193 | (1) |
|
Posttranslational modifications of HSP90 |
|
|
193 | (1) |
|
MicroRNA-mediated regulation of heat shock proteins in different cancers |
|
|
194 | (1) |
|
Diagnostic, prognostic, and predictive implications of diverse classes of HSP |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
196 | (8) |
|
14 Role of kisspeptin-mediated signaling pathway in carcinogenesis and metastasis: opposite sides of the same coin |
|
|
|
|
|
|
|
|
|
204 | (1) |
|
Antimetastatic role of KISS1 |
|
|
204 | (1) |
|
Prometastatic role of kisspeptin-driven signaling |
|
|
205 | (1) |
|
Regulation of kisspeptin by noncoding RNAs |
|
|
205 | (1) |
|
|
206 | (1) |
|
|
207 | (3) |
|
15 Tumor microenvironment manipulation and cancer metastasis (taming the beast) |
|
|
|
|
|
|
210 | (1) |
|
|
210 | (1) |
|
The complexity of metastatic colonization |
|
|
211 | (1) |
|
The tumor microenvironment |
|
|
211 | (1) |
|
Tumor genesis and metastasis |
|
|
212 | (1) |
|
Epithelial---mesenchymal transition |
|
|
212 | (4) |
|
Relation between epithelial mesenchymal transition and vascularization |
|
|
216 | (1) |
|
Component of tumor microenvironment |
|
|
216 | (7) |
|
Implication in translational research |
|
|
223 | (1) |
|
|
224 | (2) |
|
Futures research and challenges |
|
|
226 | (1) |
|
Understanding TMI for effective immunotherapy |
|
|
226 | (1) |
|
|
227 | (8) |
|
16 Metastasis inhibitory role of hydroxycinnamic acid and its derivatives |
|
|
|
|
|
|
|
|
235 | (2) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (2) |
|
|
239 | (1) |
|
|
239 | (3) |
|
17 Regulatory role of SMURF1 and SMURF2 in metastasis: multitalented SMURFs take the central stage |
|
|
|
|
|
|
|
|
242 | (1) |
|
Prometastatic role of SMURF1 |
|
|
242 | (1) |
|
Metastasis inhibitory role of SMURF1 |
|
|
243 | (1) |
|
|
243 | (4) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (2) |
|
18 Antimetastatic effects of curcumin |
|
|
|
|
|
|
|
|
249 | (1) |
|
Metastasis inhibitory role of curcumin |
|
|
250 | (2) |
|
Curcumin and nanotechnology |
|
|
252 | (2) |
|
|
254 | (1) |
|
|
254 | (6) |
|
19 Metastasis inhibitory role of blueberries: time to play gooseberry with oncogenic cascades and metastasis |
|
|
|
|
|
|
|
|
260 | (1) |
|
Inhibition of carcinogenesis and metastasis by different berries: preclinical studies |
|
|
261 | (1) |
|
Metastasis inhibitory roles of blueberry |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (3) |
|
20 The role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior |
|
|
|
|
|
|
|
|
Enma Veronica Paez Espinosa |
|
|
|
|
|
|
|
266 | (1) |
|
The EMT process in thyroid cancer progression |
|
|
267 | (1) |
|
ABC-binding cassette transporters in ETC progression |
|
|
268 | (5) |
|
Future perspectives: the ABC transporters and EMT paradigm in ETC |
|
|
273 | (1) |
|
|
273 | (1) |
|
|
273 | (4) |
|
21 The role of epigenetics in cancer metastasis |
|
|
|
|
|
|
|
|
|
277 | (2) |
|
DNA methylation and metastasis |
|
|
279 | (2) |
|
|
281 | (6) |
|
|
287 | (4) |
|
Exosomes and premetastatic niche formation |
|
|
291 | (2) |
|
|
293 | (1) |
|
|
294 | (1) |
|
|
294 | (8) |
|
22 Regulation of angiogenesis in tumor metastasis via Ets-related ERG and micro-RNAs; one hand washes the other |
|
|
|
|
|
|
|
|
302 | (1) |
|
|
303 | (2) |
|
Crosstalk of ERG with other proteins or signaling cascades |
|
|
305 | (1) |
|
|
305 | (5) |
|
|
310 | (1) |
Conclusion |
|
311 | (1) |
References |
|
312 | (5) |
Index |
|
317 | |